Skip to main content
Premium Trial:

Request an Annual Quote

Phenomenex to Distribute Beckman’s Protein/Peptide-Separation Tool

NEW YORK (GenomeWeb News) — Phenomenex today said it will distribute Beckman Coulter’s protein-partitioning and depletion product in North America and in Europe.
 
Under the agreement, Torrance, Calif.-based Phenomenex will market and sell Beckman’s ProteomeLab IgY-12. The IgY is based on avian-generated antibodies and “delivers an enriched proteome that includes medium and low-abundance proteins that are of interest to biomarker research,” Phenomenex said.  
 
Michael McGinley, Phenomenex’s biochromatography product manager, said the IgY will “fit well” with the company’s proteomics offerings for protein and peptide separation.
 
Financial terms of the agreement were not released.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.